Смотреть

Весь архив

Главная
по журналам

по журналам "Accounts in Drug Discovery: Case Studies in Medicinal Chemistry"

Отображаемые элементы 1-20 из 20

Chapter 1. The Discovery of the Dipeptidyl Peptidase-4 (DPP4) Inhibitor Onglyza™: From Concept to Market

Robl, Jeffrey A.; Hamann, Lawrence G. (Royal Society of Chemistry, 2011)
Chapter 10. The Discovery of GS-9131, an Amidate Prodrug of a Novel Nucleoside Phosphonate HIV Reverse Transcriptase Inhibitor

Mackman, Richard (Royal Society of Chemistry, 2011)
Chapter 11. 2′-F-2′-C-Methyl Nucleosides and Nucleotides for the Treatment of Hepatitis C Virus: from Discovery to the Clinic

Sofia, Michael J.; Furman, Phillip A.; Symonds, William T. (Royal Society of Chemistry, 2011)
Chapter 12. A Case History on the Challenges of Central Nervous System and Dual Pharmacology Drug Discovery

Fish, Paul V.; Harrison, Anthony; Wakenhut, Florian; Whitlock, Gavin A. (Royal Society of Chemistry, 2011)
Chapter 13. The Discovery of TRPV1 Antagonists: Turning up the Heat

Norman, Mark H. (Royal Society of Chemistry, 2011)
Chapter 14. Uncoupling Neuroprotection from Immunosuppression: the Discovery of ILS-920

Graziani, Edmund I. (Royal Society of Chemistry, 2011)
Chapter 15. Identification of α7 Nicotinic Acetylcholine Receptor Agonists for their Assessment in Improving Cognition in Schizophrenia

Rogers, Bruce N.; Jon Jacobsen, E.; O’Donnell, Christopher J.; Shaffer, Christopher L.; Walker, Daniel P.; Wishka, Donn G. (Royal Society of Chemistry, 2011)
Chapter 2. The Discovery of Vorapaxar (SCH 530348), a Thrombin Receptor (Protease Activated Receptor-1) Antagonist with Potent Antiplatelet Effects

Chackalamannil, Samuel (Royal Society of Chemistry, 2011)
Chapter 3. The Discovery of Piragliatin, a Glucokinase Activator

Sarabu, Ramakanth; Tilley, Jefferson W.; Grimsby, Joseph; Sarabu Ramakanth; Departments of Discovery Chemistry; Tilley Jefferson W.; Departments of Discovery Chemistry; Grimsby Joseph; Metabolic and Vascular Diseases (Royal Society of Chemistry, 2011)
Chapter 4. The Discovery of OSI-906, a Small-molecule Inhibitor of the Insulin-like Growth Factor-1 and Insulin Receptors

Mulvihill, Mark J.; Buck, Elizabeth (Royal Society of Chemistry, 2011)
Chapter 5. The Genesis of the Antibody Conjugate Gemtuzumab Ozogamicin (Mylotarg®) for Acute Myeloid Leukemia

Hamann, Philip R. (Royal Society of Chemistry, 2011)
Chapter 6. Novel Androgen Receptor Antagonists for the Treatment of Prostate Cancer

Gavai, Ashvinikumar V.; Foster, William R.; Balog, Aaron; Vite, Gregory D. (Royal Society of Chemistry, 2011)
Chapter 7. The Discovery of UK-390957: the Challenge of Targeting a Short Half-life, Rapid Tmax SSRI

Andrews, Mark D.; Middleton, Donald S. (Royal Society of Chemistry, 2011)
Chapter 8. The Discovery of the Long-acting PDE5 Inhibitor PF-489791 for the Treatment of Pulmonary Hypertension

Bell, Andrew S.; Palmer, Michael J. (Royal Society of Chemistry, 2011)
Chapter 9. From HTS to Market: the Discovery and Development of Maraviroc, a CCR5 Antagonist for the Treatment of HIV

Barber, Chris; Pryde, David (Royal Society of Chemistry, 2011)
Contents

Barrish, Joel C.; Carter, Percy H.; Cheng, Peter T. W.; Zahler, Robert (Royal Society of Chemistry, 2011)
Foreword

Barrish, Joel C.; Carter, Percy H.; Cheng, Peter T. W.; Zahler, Robert (Royal Society of Chemistry, 2011)
Front Matter

Barrish, Joel C.; Carter, Percy H.; Cheng, Peter T. W.; Zahler, Robert (Royal Society of Chemistry, 2011)
Preface

Barrish, Joel C.; Carter, Percy H.; Cheng, Peter T. W.; Zahler, Robert (Royal Society of Chemistry, 2011)
Subject Index

Barrish, Joel C.; Carter, Percy H.; Cheng, Peter T. W.; Zahler, Robert (Royal Society of Chemistry, 2011)

Отображаемые элементы 1-20 из 20

Смотреть

Весь архив

по журналам "Accounts in Drug Discovery: Case Studies in Medicinal Chemistry"